• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制瘤素对缺血/再灌注损伤诱导的室性心律失常的预防作用:一项初步研究。

Preventive Effect of Canstatin against Ventricular Arrhythmia Induced by Ischemia/Reperfusion Injury: A Pilot Study.

作者信息

Sugiyama Akira, Shimizu Yurie, Okada Muneyoshi, Otani Kosuke, Yamawaki Hideyuki

机构信息

Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Higashi 23 Bancho 35-1, Towada City, Aomori 034-8628, Japan.

出版信息

Int J Mol Sci. 2021 Jan 20;22(3):1004. doi: 10.3390/ijms22031004.

DOI:10.3390/ijms22031004
PMID:33498253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7863958/
Abstract

Ventricular arrhythmia induced by ischemia/reperfusion (I/R) injury is a clinical problem in reperfusion therapies for acute myocardial infarction. Ca overload through reactive oxygen species (ROS) production is a major cause for I/R-induced arrhythmia. We previously demonstrated that canstatin, a C-terminal fragment of type IV collagen α2 chain, regulated Ca handling in rat heart. In this study, we aimed to clarify the effects of canstatin on I/R-induced ventricular arrhythmia in rats. Male Wistar rats were subjected to I/R injury by ligating the left anterior descending artery followed by reperfusion. Ventricular arrhythmia (ventricular tachycardia and ventricular fibrillation) was recorded by electrocardiogram. Nicotinamide adenine dinucleotide phosphate oxidase (NOX) activity and ROS production in neonatal rat cardiomyocytes (NRCMs) stimulated with oxygen glucose deprivation/reperfusion (OGD/R) were measured by lucigenin assay and 2',7'-dichlorodihydrofluorescein diacetate staining, respectively. The HO-induced intracellular Ca ([Ca]) rise in NRCMs was measured by a fluorescent Ca indicator. Canstatin (20 µg/kg) inhibited I/R-induced ventricular arrhythmia in rats. Canstatin (250 ng/mL) inhibited OGD/R-induced NOX activation and ROS production and suppressed the HO-induced [Ca] rise in NRCMs. We for the first time demonstrated that canstatin exerts a preventive effect against I/R-induced ventricular arrhythmia, perhaps in part through the suppression of ROS production and the subsequent [Ca] rise.

摘要

缺血/再灌注(I/R)损伤诱发的室性心律失常是急性心肌梗死再灌注治疗中的一个临床问题。通过活性氧(ROS)生成导致的钙超载是I/R诱发心律失常的主要原因。我们之前证明,IV型胶原α2链的C末端片段canstatin可调节大鼠心脏中的钙处理。在本研究中,我们旨在阐明canstatin对大鼠I/R诱发的室性心律失常的影响。雄性Wistar大鼠通过结扎左前降支动脉然后再灌注来进行I/R损伤。通过心电图记录室性心律失常(室性心动过速和室颤)。分别通过光泽精测定法和2',7'-二氯二氢荧光素二乙酸酯染色来测量用氧糖剥夺/再灌注(OGD/R)刺激的新生大鼠心肌细胞(NRCMs)中的烟酰胺腺嘌呤二核苷酸磷酸氧化酶(NOX)活性和ROS生成。通过荧光钙指示剂测量HO诱导的NRCMs细胞内钙([Ca])升高。Canstatin(20μg/kg)可抑制大鼠I/R诱发的室性心律失常。Canstatin(250ng/mL)可抑制OGD/R诱导的NOX激活和ROS生成,并抑制HO诱导的NRCMs中[Ca]升高。我们首次证明,canstatin对I/R诱发的室性心律失常具有预防作用,可能部分是通过抑制ROS生成以及随后的[Ca]升高来实现的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/9ff730f12ff9/ijms-22-01004-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/5b01d941502a/ijms-22-01004-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/04b86e4a5a4e/ijms-22-01004-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/e968bfcacf54/ijms-22-01004-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/5587ad0b09a5/ijms-22-01004-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/0132e7a2359b/ijms-22-01004-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/9ff730f12ff9/ijms-22-01004-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/5b01d941502a/ijms-22-01004-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/04b86e4a5a4e/ijms-22-01004-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/e968bfcacf54/ijms-22-01004-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/5587ad0b09a5/ijms-22-01004-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/0132e7a2359b/ijms-22-01004-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54fc/7863958/9ff730f12ff9/ijms-22-01004-g006.jpg

相似文献

1
Preventive Effect of Canstatin against Ventricular Arrhythmia Induced by Ischemia/Reperfusion Injury: A Pilot Study.制瘤素对缺血/再灌注损伤诱导的室性心律失常的预防作用:一项初步研究。
Int J Mol Sci. 2021 Jan 20;22(3):1004. doi: 10.3390/ijms22031004.
2
Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.康斯他汀通过抑制大鼠心肌肥厚中环核苷酸磷酸二酯酶 5 同工酶/nFAT 通路抑制异丙肾上腺素诱导的心肌肥厚。
Eur J Pharmacol. 2020 Mar 15;871:172849. doi: 10.1016/j.ejphar.2019.172849. Epub 2019 Dec 13.
3
Protective effect of T3 peptide, an active fragment of tumstatin, against ischemia/reperfusion injury in rat heart.T3 肽(源自 tumstatin 的活性片段)对大鼠心脏缺血/再灌注损伤的保护作用。
J Pharmacol Sci. 2019 Mar;139(3):193-200. doi: 10.1016/j.jphs.2019.01.010. Epub 2019 Feb 10.
4
Cardioprotective effects of pravastatin against lethal ventricular arrhythmias induced by reperfusion in the rat heart.普伐他汀对再灌注诱导的大鼠致命性室性心律失常的心脏保护作用。
Circ J. 2011;75(7):1601-8. doi: 10.1253/circj.cj-10-1139. Epub 2011 May 25.
5
Canstatin modulates L-type calcium channel activity in rat ventricular cardiomyocytes.康抑肽调节大鼠心室肌细胞 L 型钙通道活性。
Biochem Biophys Res Commun. 2018 May 23;499(4):954-959. doi: 10.1016/j.bbrc.2018.04.026. Epub 2018 Apr 11.
6
Long-term administration of recombinant canstatin prevents adverse cardiac remodeling after myocardial infarction.长期给予重组人血管抑素可预防心肌梗死后的不良心脏重构。
Sci Rep. 2020 Jul 30;10(1):12881. doi: 10.1038/s41598-020-69736-y.
7
Glycyrrhetinic Acid protects the heart from ischemia/reperfusion injury by attenuating the susceptibility and incidence of fatal ventricular arrhythmia during the reperfusion period in the rat hearts.甘草次酸通过降低大鼠心脏再灌注期致命性室性心律失常的易感性和发生率,保护心脏免受缺血/再灌注损伤。
Cell Physiol Biochem. 2015;36(2):741-52. doi: 10.1159/000430134. Epub 2015 May 22.
8
Pathophysiological roles of canstatin on myofibroblasts after myocardial infarction in rats.大鼠心肌梗死后康司亭对肌成纤维细胞的病理生理作用。
Eur J Pharmacol. 2017 Jul 15;807:32-43. doi: 10.1016/j.ejphar.2017.04.027. Epub 2017 Apr 21.
9
Shenxian-Shengmai Oral Liquid Reduces Myocardial Oxidative Stress and Protects Myocardium from Ischemia-Reperfusion Injury.参仙升脉口服液减轻心肌氧化应激并保护心肌免受缺血再灌注损伤。
Cell Physiol Biochem. 2018;48(6):2503-2516. doi: 10.1159/000492688. Epub 2018 Aug 17.
10
Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling.同型半胱氨酸诱导肺动脉高压大鼠模型中康抑素表达降低:康抑素对右心室重构的保护作用。
Int J Mol Sci. 2020 Sep 16;21(18):6797. doi: 10.3390/ijms21186797.

引用本文的文献

1
The Versatility of Collagen in Pharmacology: Targeting Collagen, Targeting with Collagen.胶原蛋白在药理学中的多功能性:靶向胶原蛋白,用胶原蛋白靶向。
Int J Mol Sci. 2024 Jun 13;25(12):6523. doi: 10.3390/ijms25126523.
2
Risk factors for electrical storms following percutaneous coronary intervention in patients with acute myocardial infarction: A meta-analysis.急性心肌梗死后经皮冠状动脉介入治疗后电风暴的危险因素:一项荟萃分析。
Biomol Biomed. 2024 Sep 6;24(5):1077-1091. doi: 10.17305/bb.2024.10274.
3
Multi-Omics Profiling Identifies Microglial Annexin A2 as a Key Mediator of NF-κB Pro-inflammatory Signaling in Ischemic Reperfusion Injury.

本文引用的文献

1
Long-term administration of recombinant canstatin prevents adverse cardiac remodeling after myocardial infarction.长期给予重组人血管抑素可预防心肌梗死后的不良心脏重构。
Sci Rep. 2020 Jul 30;10(1):12881. doi: 10.1038/s41598-020-69736-y.
2
Calcium Handling Defects and Cardiac Arrhythmia Syndromes.钙处理缺陷与心律失常综合征
Front Pharmacol. 2020 Feb 25;11:72. doi: 10.3389/fphar.2020.00072. eCollection 2020.
3
Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
多组学分析鉴定出小胶质细胞 annexin A2 是缺血再灌注损伤中 NF-κB 促炎信号的关键介质。
Mol Cell Proteomics. 2024 Feb;23(2):100723. doi: 10.1016/j.mcpro.2024.100723. Epub 2024 Jan 20.
4
Biomimetic Cardiac Tissue Models for In Vitro Arrhythmia Studies.用于体外心律失常研究的仿生心脏组织模型
Biomimetics (Basel). 2023 Oct 14;8(6):487. doi: 10.3390/biomimetics8060487.
5
Autocrine role of senescent cardiac fibroblasts-derived extracellular vesicles.衰老心肌成纤维细胞来源的细胞外囊泡的自分泌作用。
J Vet Med Sci. 2023 Nov 2;85(11):1157-1164. doi: 10.1292/jvms.23-0279. Epub 2023 Oct 2.
6
Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury.抑制心肌细胞凋亡是人参皂苷减轻心肌缺血/再灌注损伤的重要机制。
Front Pharmacol. 2022 Mar 1;13:806216. doi: 10.3389/fphar.2022.806216. eCollection 2022.
康斯他汀通过抑制大鼠心肌肥厚中环核苷酸磷酸二酯酶 5 同工酶/nFAT 通路抑制异丙肾上腺素诱导的心肌肥厚。
Eur J Pharmacol. 2020 Mar 15;871:172849. doi: 10.1016/j.ejphar.2019.172849. Epub 2019 Dec 13.
4
Myocardial Infarction-From Atherosclerosis to Thrombosis.心肌梗死——从动脉粥样硬化到血栓形成
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):e176-e185. doi: 10.1161/ATVBAHA.119.312578. Epub 2019 Jul 24.
5
Protective effect of T3 peptide, an active fragment of tumstatin, against ischemia/reperfusion injury in rat heart.T3 肽(源自 tumstatin 的活性片段)对大鼠心脏缺血/再灌注损伤的保护作用。
J Pharmacol Sci. 2019 Mar;139(3):193-200. doi: 10.1016/j.jphs.2019.01.010. Epub 2019 Feb 10.
6
Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats.组织蛋白酶S可降解大鼠心肌梗死后梗死区域的抑制素和内皮抑素。
J Vet Med Sci. 2019 Apr 16;81(4):522-531. doi: 10.1292/jvms.18-0674. Epub 2019 Feb 7.
7
Clinical manifestations and basic mechanisms of myocardial ischemia/reperfusion injury.心肌缺血/再灌注损伤的临床表现及基本机制
Tzu Chi Med J. 2018 Oct-Dec;30(4):209-215. doi: 10.4103/tcmj.tcmj_33_18.
8
Protective effects of cinnamon bark extract against ischemia-reperfusion injury and arrhythmias in rat.肉桂皮提取物对大鼠缺血再灌注损伤及心律失常的保护作用。
Phytother Res. 2018 Oct;32(10):1983-1991. doi: 10.1002/ptr.6127. Epub 2018 Jun 19.
9
Canstatin modulates L-type calcium channel activity in rat ventricular cardiomyocytes.康抑肽调节大鼠心室肌细胞 L 型钙通道活性。
Biochem Biophys Res Commun. 2018 May 23;499(4):954-959. doi: 10.1016/j.bbrc.2018.04.026. Epub 2018 Apr 11.
10
Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury.吲哚马来酰亚胺衍生物IM-17在缺血再灌注损伤中显示出心脏保护作用。
ACS Med Chem Lett. 2018 Jan 29;9(3):182-187. doi: 10.1021/acsmedchemlett.7b00454. eCollection 2018 Mar 8.